stock-detail (ARQL)

Oncology Corporate Profile

Company Description

This company does not have any commercial products

This company does not have any pipeline products

Recent News Headlines

Anticancer Drug Restores Hearing In Some Patients With Neurofibromatosis

3/16/2016 11:04 am

(Johns Hopkins Medicine) Mar 14, 2016 - In a small clinical study with an anticancer drug that halts blood vessel growth, a handful of people with neurofibromatosis type 2 (NF2) and hearing loss had restoration of hearing.

UPMC-Developed Test Rapidly, Accurately Profiles Genetics and Treatment of Brain Tumors

1/28/2016 11:04 am

(UPMC) Jan 27, 2016 - Brain tumors can be rapidly and accurately profiled with a next-generation, gene-sequencing test developed at UPMC and the University of Pittsburgh School of Medicine.

In Pancreatic Cancer, If CA 19-9 Is Up, Then Chemo First

11/10/2015 11:03 am

(Medscape Medical News) Nov 9, 2015 - Changing the standard sequence of treatment for operable pancreatic cancer could improve survival for some patients, say researchers.

Sorafenib Modestly Increases Progression-Free Survival But Not Overall Survival In NSCLC Patients Who Failed Previous Therapies

11/10/2015 11:03 am

(IASLC) Nov 9, 2015 - Sorafenib, a tyrosine kinase inhibitor (TKI) targeting the receptors for vascular endothelial growth factor, platelet derived growth factor, and mast/stem cell growth factor, modestly increases progression-free survival (PFS), time to progression, and disease control rate in non-small cell lung cancer (NSCLC) patients who have relapsed or failed two or three previous treatment regimens.

New Test For Prostate Cancer Significantly Improves Screening

11/10/2015 11:03 am

(Karolinska Institutet [Sweden]) Nov 10, 2015 - A study from Karolinska Institutet in Sweden shows that a new test for prostate cancer is better at detecting aggressive cancer than PSA.

Offer It: Third-Line Therapy Effective in Metastatic RCC

11/10/2015 11:03 am

(Medscape Medical News) Nov 9, 2015 - The use of third-line targeted therapy is prevalent in patients with metastatic renal cell carcinoma (mRCC), and has demonstrated activity in this population. Therefore, it should be offered to clinically eligible patients, according to the authors of a new study.

Lilly Diabetes Drug Cuts Heart Failure Death, Hospitalization: Study

11/9/2015 01:01 pm

(Reuters) Nov 9, 2015 - Eli Lilly's new diabetes drug Jardiance significantly cut the risk of heart-related death and hospitalization for heart failure in patients with type 2 diabetes who are at high risk for serious heart problems, according to data from a large study presented on Monday.

Cytokinetics, Amgen Drug Shows Promise In Heart Failure Study

11/9/2015 01:00 pm

(Reuters) Nov 8, 2015 - An experimental heart failure drug being developed by Cytokinetics Inc and Amgen Inc demonstrated several beneficial cardiac function effects in a midstage clinical trial, according to data presented on Sunday.

Op-Ed: I Am Paying for Your Expensive Medicine

11/9/2015 01:00 pm

(New York Times) Nov 7, 2015 - YOU may not know it, but you could be on the hook to pay at least $124 this year for a drug you probably don’t take.

Google, American Heart Association Announce Joint Research Effort

11/9/2015 12:02 pm

(Wall Street Journal) Nov 8, 2015 - Five-year, $50 million collaboration intended to bring new approaches to research of heart disease.

Calif. Medicaid Patients With Cancer Fare Worse Than Those With Other Coverage

11/9/2015 12:00 pm

(Kaiser Health News) Nov 6, 2015 - Cancer patients insured by California’s health plan for low-income people are less likely to get recommended treatment and also have lower survival rates than patients with other types of insurance, according to a new study by University of California-Davis researchers.

Scientist Falsified Data For Cancer Research Once Described As ‘Holy Grail,’ Feds Say

11/9/2015 11:03 am

(Washington Post/Morning Mix) Nov 9, 2015 - One Duke University surgeon called it a “new frontier” in cancer treatment. Another said it could save “10,000 lives a year” or more.

Miami Cancer Institute Appoints Michael Zinner, M.D., Founding Chief Executive Officer & Executive Medical Director

11/9/2015 11:03 am

(Yahoo! Finance) Nov 9, 2015 - Michael J. Zinner, M.D., a world-renowned and highly respected cancer surgeon and researcher, has been named founding CEO and executive medical director of Miami Cancer Institute at Baptist Health South Florida, announced Brian E. Keeley, president and CEO of Baptist Health South Florida.

Plavix (clopidogrel): Drug Safety Communication - Long-term Treatment Does Not Change Risk of Death

11/9/2015 11:03 am

( Nov 6, 2015 - ISSUE: An FDA review has determined that long-term use of the blood-thinning drug Plavix (clopidogrel) does not increase or decrease overall risk of death in patients with, or at risk for, heart disease. FDA evaluation of the Dual Antiplatelet Therapy (DAPT) trial and several other clinical trials also does not suggest that clopidogrel increases the risk of cancer or death from cancer.

Flatiron Health Unveils New Features and Enhancements to the OncologyCloudTM Software Platform

11/9/2015 11:03 am

(Yahoo! Finance) Nov 9, 2015 - Industry-first OncoAnalyticsTM data application now includes some of the most advanced billing operations analytics for community oncology practices and cancer centers.

Roche Signs Cancer Trial Pact with Amgen

6/2/2015 04:03 pm

(PharmaTimes [UK]) June 2, 2015 - Roche and Amgen will work together on a Phase Ib study looking at the safety and efficacy of combining their respective immunotherapies atezolizumab and T-VEC in patients with triple-negative breast cancer and colorectal cancer with liver metastases.

Study Finds Cancer Link for Muscle-building Supplements

4/13/2015 11:04 am

(Brown University) Apr 13, 2015 — Men who reported taking muscle-building supplements, such as pills and powders with creatine or androstenedione, reported a significantly higher likelihood of having developed testicular cancer than men who did not use such supplements, according to a new study in the British Journal of Cancer.

Deaf or Death? In Drug Trial, Parents Weigh Life vs. Hearing Loss

3/2/2015 12:02 pm

(Wall Street Journal) Mar 1, 2015 - An experimental treatment could let children with a rare genetic disease live longer, but it may make them deaf.

UV Light Accelerates Cancer Cells That Creep Along the Outside of Blood Vessels

3/11/2014 11:04 am

(UCLA) Mar 10, 2014 - A new study provides additional support for a process by which melanoma cells, a deadly form of skin cancer, can spread throughout the body by creeping like tiny spiders along the outside of blood vessels without ever entering the blood stream, and that this process is exacerbated by exposure to ultraviolet (UV) light.

Several FDA-Approved Anti-Cancer Drugs Induce Stem Cell Tumors, Perhaps Thwarting Therapy

3/11/2014 11:04 am

(UMass Amherst) Mar 10, 2014 - Using a new approach to systematically test chemotherapy drugs in an unusual animal model, a research team reports that several have a serious side effect: Inducing hyper proliferation in stem cells that could lead to tumor recurrence.

Do ‘Sticky’ Cells Cause Cancer Drug Resistance?

3/11/2014 11:04 am

(Drug Discovery & Development) Mar 10, 2014 - Researchers in Manchester have investigated the stickiness of leukemia cells, and whether this is linked to drug resistance.

Tocagen Doses First Patient Intravenously in Clinical Trial of Selective Cancer Therapy, Toca 511 & Toca FC

3/11/2014 11:04 am

( Mar 11, 2014 - Tocagen Inc. today announced that the first patient has been dosed in its clinical trial investigating the intravenous administration of selective cancer therapy Toca 511 & Toca FC, in patients with recurrent high grade glioma (HGG) including glioblastoma multiforme (GBM, Grade 4 HGG).

Cheaper, More Aggressive Prostate Cancer Treatment May Also Be Riskier

3/11/2014 11:03 am

(Yale News) Mar 10, 2014 - A faster and less expensive form of radiotherapy for treating prostate cancer may come at a price, according to a new study by Yale School of Medicine researchers — a higher rate of urinary toxicity or urine poisoning.

More Body Fat Raises Ovarian Cancer Risk, Study Suggests

3/11/2014 11:03 am

( Mar 10, 2014 - The more a woman weighs, the greater her risk of ovarian cancer, a new report suggests.

UC Davis Researchers One Step Closer to Ovarian Cancer Marker

3/11/2014 11:03 am

(UC Davis Health System) Mar 10, 2014 - Researchers at UC Davis have verified that glycans (sugars attached to proteins) can be used to detect ovarian cancer. The study was published online in the journal Cancer Epidemiology, Biomarkers & Prevention.